cbdMD, Inc. (YCBD)

Market Cap	2.97M
Revenue (ttm)	26.30M
Net Income (ttm)	-25.70M
Shares Out	2.86M
EPS (ttm)	-17.75
PE Ratio	n/a
Forward PE	714.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	95,091
Open	1.08
Previous Close	1.10
Day's Range	1.02 - 1.25
52-Week Range	1.02 - 20.25
Beta	2.15
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2023

About YCBD

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. It distributes its products through its e-commerce website, third-party e-commerce sites, wholesalers, and various brick an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2015
• Employees: 90
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: YCBD

Financial Performance

In 2022, cbdMD's revenue was $35.40 million, a decrease of -20.41% compared to the previous year's $44.48 million. Losses were -$74.09 million, 185.5% more than in 2021.